[go: up one dir, main page]

Kutkiene et al., 2019 - Google Patents

Prevalence And Aging Tendencies Of Cardiometabolic Risk Factors In Middle-Aged Lithuanian Women

Kutkiene et al., 2019

View PDF
Document ID
6686798628314983750
Author
Kutkiene S
Gargalskaite U
Petrulionyte E
Rinkuniene E
Skiauteryte E
Laucevicius A
Publication year
Publication venue
Atherosclerosis

External Links

Snippet

Methods: Out of total 92 373 people, 53 961 women were evaluated during period of 2009- 2016. This study recruited women aged 50-64 without overt CVD. Women were divided into three age groups: first age group included women aged 50-54, second-55-59, third-60-64 …
Continue reading at www.atherosclerosis-journal.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/10—Eye inspection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes

Similar Documents

Publication Publication Date Title
Azad et al. Asymmetric diabetic retinopathy
Zelefsky et al. Escitalopram-induced uveal effusions and bilateral angle closure glaucoma
Çekiç et al. Effects of obesity on retrobulbar flow hemodynamics: color Doppler ultrasound evaluation
Iyizoba et al. Doppler ultrasound features of ophthalmic artery in diabetic retinopathy in a Nigerian Teaching Hospital
Kutkiene et al. Prevalence And Aging Tendencies Of Cardiometabolic Risk Factors In Middle-Aged Lithuanian Women
Stradins et al. Vitamin D Level Impact On Cardiac Surgery Patient Outcome
Lachmann et al. Scleritis and associated disease.
Flórez et al. Suprachoroidal hemorrhage due to Valsalva maneuver, importance of enhanced depth imaging optical coherence tomography in differential diagnosis
Egan Diabetes-related microvascular complications: What every nurse practitioner needs to know
Janisch et al. [PP. 21.08] THE RELATION OF ARTERIAL HYPERTENSION AND TARGET ORGAN DAMAGE IN THE SWISS HYPERTENSION COHORT STUDY
Roncone et al. Conjunctival chemosis: A case series of systemic causes
Rivero et al. PREVALENCE OF ORGANIC DAMAGE AND SUBCLINICAL LESIONS IN REFRACTORY HYPERTENSION: PP. 42.359
RU2295295C2 (en) Method for predicting vascular pathology of optic nerve
Mulia et al. 45. Morbidity of Hemodialisis Patients: Focus on the Incident Rate of Cataract Surgery and Anemia with Blood Transfusion at OKU Timur Hospital
Salvetti et al. RESISTANT HYPERTENSION IN A GENERAL POPULATION IN NORTHERN ITALY: PREVALENCE, ASSOCIATED CARDIOVASCULAR RISK FACTORS AND TARGET ORGAN DAMAGE: PP. 42.362
Murakami et al. PS 02-13 ANTI-ATHEROSCLEROTIC EFFECT OF MILD BILIRUBIN ELEVATION IS MASKED BY THE CONFOUNDING FACTOR OF FATTY LIVER AND ABDOMINAL OBESITY IN THE APPARENTLY HEALTHY JAPANESE MIDDLE-AGED PEOPLE
Medvedeva et al. Impared metabolism of VEGF-A, HGF, IGF-1, G-CSF and GM-CSF in the progression of obesity in patients with gout
Karadag et al. POS0138 DOES CRANIAL GIANT CELL ARTERITIS (GCA) AFFECT BRANCHES OF BOTH EXTERNAL AND INTERNAL CAROTID ARTERIES A TRANSORBITAL DOPPLER ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY STUDY
Petrulioniene et al. Comparison Of Lipid Profile Between Different Degrees Of Obesity According To Body Mass Index In Middle-Aged Lithuanian Women
Triono et al. 44. The Relationship between P Wave and Corrected QT Dispersion with The Left Ventricular Ejection Fraction (LVEF) and The Severity of Coronary Artery Stenosis in Coronary Artery Disease: A Cross-sectional study
Pogorelova et al. Flow-mediated dilation of the brachial artery in patients with obesity after COVID-19
Mikhail Comparative Evaluation of the Influence of the Factors of the Progress of Diabetic Retinopathy on the Procoagulating Potential of Blood at Metabolic Syndrome
Pradnyana et al. 33. CHARACTERISTICS AND COMORBIDITIES OF HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC
Yasinska The risk of cardiovascular diseases in patients with arterial hypertension
Çekiç et al. Efeitos da obesidade na hemodinâmica do fluxo retrobulbar: avaliação por ultrassom doppler colorido